The output “Ozone Pharmaceuticals” on an IPO turned into a loud failure. The money received will not be able to close the multi -billion dollar debts of the company.
The company “Ozon Pharmaceuticals” reached an IPO and attracted 3.45 billion rubles when placing shares on the upper border of 35 rubles. However, on the first day, the quotes sank by 5.7% to 33 rubles. Perhaps this is due to the fact that the organization plans to spend the borrowed money on the closure of numerous debt obligations.
The correspondent of The Moscow Post in the Samara region understood the history.
“Ozone Pharmaceuticals”
The legal entity of the pharmaceutical business is PJSC “Ozon Pharmaceuticals”, which is the successor of Ozon Pharmaceutical LLC. Ozon Pharmaceutical LLC, before closing in May 2024, had many co -founders, but leading roles were played by Pavel Alekseenko (43.99%), Yuri Kornev (15.93%), Vladimir Kornev (11.99%) and LLC Alvils Group.
Photo: Rusprofile.ru
Alekseenko, Kornevs and Vitaly Aleinikov through Alvils Group and are the beneficiaries of business, which they wanted to sell more in 2020. The problem was that the production of cheap generics has become unprofitable – we are talking about standard medicines, the prices for which the state regulates. It was such drugs in the total mass that produced “Ozone Pharmaceuticals”. Only the sale did not take place, and in 2024 the company estimates its capitalization, taking into account the 3.45 billion rubles involved at the IPO 38.5 billion rubles.
The figure is important, and four years earlier, the owners were ready to give in to the business for 10 billion rubles. Where does this difference come from? How so quickly could the bubble pout?
The debt trap
The organization has a very difficult situation with debts. The profit of Ozon Pharmaceutical LLC in 2023 amounted to 1 billion rubles with receivables of 1.4 billion rubles and a payable – 509 million rubles. The load is significant, but there are still subsidiaries. All these problems have switched to PJSC “Ozon Pharmaceuticals”.
Photo: Rusprofile.ru
Ozon LLC has a revenue of 18 billion rubles for 2023, receivables of 11 billion rubles and a payable – at 4.9 billion rubles. The company is obligations to Sberbank, VTB and “Junikredit with a bank”.
Ozon Farm LLC has a revenue of 4.7 billion rubles, receivables of 2.3 billion rubles and payable – 675 million rubles. This structure, apparently, has obligations to VTB. The most interesting case is Mabskail LLC. The revenue of the organization is zero, but net profit is negative, minus 894 million rubles. Accounts receivable – at 104 million rubles and a payable – at 102 million rubles, but the main thing is not, but the fact that this company took a loan of 14.1 billion rubles from the VTB guarantee of Ozon LLC. The situation with Sberbank, Gref Gref, Mabskail LLC, took 19.6 billion rubles under the guarantee of Ozon LLC LLC. Both loans together are almost equal to the capitalization of PJSC “Ozon Pharmaceuticals”.
Where is the money?
Money at Sberbank LLC Mabskail, apparently, took to implement the project in OEZ PPT “Tolyatti”. Ozon Pharma, Ozon Medica and other daughters of PJSC Ozon Pharmaceuticals are also registered there.
Yuri Kornev. Photo: https://oboz.info/wp-content/uploads/2021/10/ozon-farm-26.jpeg
The company has been developing production at the OEZ PPT Togliatti since the middle of the tenths, and several years ago I decided to increase the power, which I gained loans. Only a debit with a loan does not converge here – for example, the “Medica Ozone” was supposed to invest 3.5 billion rubles in this project, but this amount is much less than loans that were scored by other daughters of PJSC Pharmaceuticals PJSC, and the organization itself does not conduct commercial activities. Its revenue is zero, so the data is 3.5 billion rudders They came from the side.
Only the Federal Tax Service verification can draw categorical conclusions, but there were suspicions that the money that was scored by PJSC “Ozon Pharmaceuticals” could go not only to business, but also to other needs, including, quite possibly, to the beneficiaries of the enterprise. For example, Yuri Kornev seems to build a 31 meter yacht In Balakovo.
The collapse is soon?
The whole business of PAO “Ozon Pharmaceuticals” is Zakreditati, and in order not to shine it, subsidiaries are used that are entrusted to each other, and occupy billions of rubles so. A kind of pyramid arose, where the stock market was connected through the IPO.
Yuri and Vladimir Korneva. Photo: https://avatars.dzeninfra.ru/get-zen_doc/1912454/pub_64d0e3D9842E0D4A2FB7C429_6407267B6A31F47D7A/SCALE_1200
If suddenly the structures of PJSC “Ozon Pharmaceuticals” have problems with servicing some of the large loans, then the whole structure may collapse overnight. Such risks exist – the company entered an IPO, including in order to close debt obligations. Only in Ozone they planned to receive 10 billion rubles from an IPO, and 3.45 billion rubles were released. At the same time, the business is not the most marginal – the company cannot count on a sharp increase in profits, so all this can collapse at any time like a card house.
According to the estimates, the Ozonovites took on credit the amount, which is 115.26% of the cost of the entire Ozone group. Debt here on duty and Clutching a duty.
From vodka to IPO
It is important that the partners in 2020 wanted to sell the whole business, and then it was fanned four times due to debts. It seems that this financial operation is a new project of these dubious personalities.
The roots of the history of PJSC “Ozon Pharmaceuticals” go away in the nineties, when the Kornev brothers tried to earn a penny with various small businesses – jeans, furniture and other trade, and in 1998 they grown before the opening of vodka business in their native Zhigulevsk (Samara region). So appeared OJSC Zhigulevsky Vodka Plant, which was registered in 2005 and since then periodically attracts the attention of law enforcement agencies.
Pavel Alekseenko. Photo: https://oeztlt.ru/uploads/gallery/69/photo-id-1725.jpg
The plant had problems with licenses, the production of vodka was stopped at the request of the control bodies, and the company itself was held accountable for the sale of vodka below the minimum allowable Prices.
After vodka, Kornevs got into pharmaceuticals and entered the capital of the Togliatti Vitafarm pharmacy network, where they soon received problems with local authority Vitaly Zykov. He did not want to give the root control of privatized pharmacies to root, which is why the counterparties had disagreements that the native of Uzbekistan Alekseenko arose.
Today “Vitafarm” is controlled by the family Zykovaand Alekseenko is listed as the main beneficiary of PJSC “Ozon Pharmaceuticals”. Rumor has it that Alekseenko, who worked in the structures of Oleg Deripaska and in 2010 was convicted of extortionsimply offered root protection from the sharks of the capitalist world. So he became the general director of Ozon Pharmaceutical LLC. It cannot be excluded that Alekseenko’s decisive capabilities, ultimately, abut in his connection with Deripaska, and he never does anything just like that.
In addition, Alekseenko attracted his friend Aleinikov to the business, who, together with LLC, Alvils Group, became the fourth player of this suspicious business, who first reached the production of cancer, and then, instead of selling from the hammer, with debts, even significantly exceeding the total cost of the company.